Please Wait
Applying Filters...
menu
    • menu
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Valerone

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Valor Compounding Pharmacyâ„¢ is Among Nominated 50 Best Companies to Watch 2021
    Valor Compounding Pharmacyâ„¢ is Among Nominated 50 Best Companies to Watch 2021

    05 Aug 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210805005283/en

    BUSINESSWIRE
    05 Aug 2021
    Share Share
    Valor Compounding Pharmacy™ is the Choice for Hormone Testing and Balancing
    Valor Compounding Pharmacy™ is the Choice for Hormone Testing and Balancing

    26 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210624005864/en

    BUSINESSWIRE
    26 Jun 2021
    Share Share
    Valor Compounding Pharmacy™ Holds 23 State Licenses
    Valor Compounding Pharmacy™ Holds 23 State Licenses

    17 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210617005203/en

    BUSINESSWIRE
    17 Jun 2021
    Share Share